FREE Virtual Study Fair | 5-6 July | REGISTER NOW FREE Virtual Study Fair | 5-6 July | REGISTER NOW

We have 30 fibrosis PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


fibrosis PhD Projects, Programmes & Scholarships

We have 30 fibrosis PhD Projects, Programmes & Scholarships

PhD saved successfully

Understanding the role of the immune system in progression of fibrosis

The pathogenic mechanism of pulmonary fibrosis (PF) is still not well understood. Initially believed to be a side effect of dysregulated inflammatory processes as the main driver, data now appears not to support this. Read more

Advanced magnetic resonance imaging methods for imaging the lungs of people with cystic fibrosis

Magnetic Resonance Imaging (MRI), and specifically functional MRI using hyperpolarised xenon-129 (129Xe-MRI), is a powerful imaging technique that provides detailed and sensitive information about lung diseases such as Cystic fibrosis (CF). Read more

Development of Nanomaterials for Targeting the Bacteria–Host Interface in Cystic Fibrosis Airways

The attachment of Pseudomonas aeruginosa (PA) to the airway mucus in the lungs of people with cystic fibrosis (CF) represents an important step in airway colonization and the subsequent development of lung infection. Read more

Development of deep learning methods and software to infer pathway enrichment from histology images - application to liver fibrosis

Histopathological images are routinely used to characterize complex phenotypes. For example, pathologists regularly study stained images of tissue biopsies for cancer diagnosis as cancer is known to change the morphological features of cells including cell shape and size [1]. Read more

Investigating innate immune dysfunction across inflammatory and fibrotic pulmonary disease

We are seeking talented, motivated students with a passion for research in acute or chronic pulmonary diseases (e.g. Pneumonia, Acute Respiratory Distress Syndrome, Interstitial Lung Diseases) to join Dr Rahul Mahida’s team in the Institute of Inflammation and Ageing at the University of Birmingham (. Read more

Refractory properties of myocardial borderzone in the human ventricle

Sudden cardiac death is the mechanism of death in more than 50% of cardiovascular related deaths and is frequently due to ventricular arrhythmias (VA).​1​ The most common mechanism underlying VA is reentry, whereby one or more self-sustaining wavefronts of electrical activation result in extreme tachycardias associated with cardiac arrest. Read more

Understanding why cardiovascular complications are the number one cause of death in patients with End-Stage Kidney Disease

Background. End-stage Kidney failure, also known as End-Stage Kidney Disease (ESKD), is the final, irreversible stage of chronic kidney disease (CKD), where kidney function has worsened to the point that the kidneys can no longer function independently. Read more

Clinical: Gastroesophageal reflux in respiratory disease: pathogenic role and improved management

Gastroesophageal reflux disease (GERD) is a condition in which stomach contents, such as food and acid pass into the gullet/oesophagus causing heartburn. GERD is very common in patients with lung disease, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Read more

Filtering Results